MicroRNA-451 as an Early Predictor of Chronic Kidney Disease in Diabetic Nephropathy
International Journal of Nephrology · 14.08.2020 · 2020 · 1-7
DOI: 10.1155/2020/8075376 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Nephrology, erschienen am 14.08.2020. Verfasst von Mostafa Abdelsalam und 3 weiteren Autor:innen. Beteiligte Einrichtung: Mansoura Nephrology and Dialysis Unit, Internal Medicine Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Diabetes mellitus is the leading cause of end-stage renal disease worldwide. Microalbuminuria is the cornerstone for the diagnosis of diabetic nephropathy. However, it is an inadequate marker for early diagnosis. MicroRNAs are not only new and promising markers for early diagnosis but also, but they may also play a role in the prevention of disease progression.
Methods
This study included ninety patients with type 2 DM in addition to 30 control subjects. MicroRNA-451 expression in blood and plasma using real-time PCR was evaluated in addition to the classic diabetic nephropathy markers (serum creatinine, urinary albumin, and eGFR).
Results
There was a significant difference between the studied groups versus control regarding serum creatinine, eGFR, urinary, and plasma microRNA-451 with p = 0.0001 . Patients with eGFR 60 ml/min/1.73 m 2 showed a significantly higher plasma microRNA-451 (29.6 ± 1.6) and significantly lower urinary microRNA-451 (21 ± 0.9) in comparison to patients with eGFR >60 ml/min/1.73 m 2 and p = 0.0001 . eGFR showed a positive correlation with urinary microRNA-451 and negative correlation with both plasma microRNA-451 and urinary albumin. Both plasma and urinary microRNA-451 are highly sensitive and specific markers for chronicity in diabetic nephropathy patients with sensitivity of 90.9% and 95.5% and specificity of 67.6% and 95.6%, respectively.
Conclusion
MicroRNA-451 is a promising early biomarker for chronic kidney disease in diabetic nephropathy with high sensitivity and specificity.
Autor:innen und Institutionen
- Mansoura Nephrology and Dialysis Unit, Internal Medicine Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt.
- Clinical Pathology Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt.
- Endocrinology Unit, Internal Medicine Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt.
ORCID-Profile: Mohamad Motawea
Zitieren
APA
Abdelsalam, M., Wahab, A. M., El Sayed Zaki, M., & Motawea, M. (2020). MicroRNA-451 as an Early Predictor of Chronic Kidney Disease in Diabetic Nephropathy. International Journal of Nephrology, 2020, 1-7. https://doi.org/10.1155/2020/8075376
Vancouver
Abdelsalam M, Wahab AM, El Sayed Zaki M, Motawea M. MicroRNA-451 as an Early Predictor of Chronic Kidney Disease in Diabetic Nephropathy. International Journal of Nephrology. 2020;2020:1-7. doi:10.1155/2020/8075376
BibTeX
@article{Abdelsalam2020,
author = {Abdelsalam, Mostafa and Wahab, A M and El Sayed Zaki, Maysaa and Motawea, Mohamad},
title = {MicroRNA-451 as an Early Predictor of Chronic Kidney Disease in Diabetic Nephropathy},
journal = {International Journal of Nephrology},
year = {2020},
volume = {2020},
pages = {1--7},
doi = {10.1155/2020/8075376}
}
EUVIMED